Si(IV)-methoxyethylene-glycol-naphthalocyanine: Synthesis and pharmacokinetic and photosensitizing properties in different tumour models

Journal of Photochemistry and Photobiology B: Biology

Volumn 40, Issue 3, 1997, Pages 258-262

  Mantareva, V ^a   Shopova, M ^a   Spassova, G ^a   Wohrle D ^b   Muller, S ^b   Jori, G ^c   Ricchelli, F ^c  

^a INSTITUTE OF ORGANIC CHEMISTRY   (Bulgaria)

^b UNIVERSITY OF BREMEN   (Germany)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cremophor EL; Pharmacokinetics; Photosensitization; Si(IV) naphthalocyanine; Synthesis; Tumour models

Indexed keywords

CREMOPHOR; SILICON DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TRANSPLANTATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG RESPONSE; DRUG SYNTHESIS; DRUG TARGETING; DRUG TISSUE LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; LEWIS CARCINOMA; MALE; MELANOMA B16; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; DISEASE MODELS, ANIMAL; LUNG NEOPLASMS; MALE; MELANOMA, EXPERIMENTAL; METALLOPORPHYRINS; MICE; MICE, INBRED C57BL; PHOTOCHEMOTHERAPY; PORPHYRINS; RADIATION-SENSITIZING AGENTS;

ANIMALIA;

EID: 0030693635     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(97)00066-3     Document Type: Article

References (17)

1. S.L. Marcus, Photodynamic Therapy: Clinical applications, a review, in: C.J. Gomer, (ed.), Future Directions and Applications of Photodynamic Therapy, Vol. 156, SPIE, Bellingham, WA, 1990, pp. 1-23,
2. G. Jori, Factors controlling the selectivity and efficiency of tumour damage in photodynamic therapy, Lasers Med. Sci., 5 (1990) 115-120.
3. R. Biolo, G. Jori, M. Soncin, R. Pratesi, U. Vanni, B. Rihter, M.E. Kenney and M.A.J. Rodgers, Photodynamic therapy of B16 pigmented melanoma with liposome-delivered Si(IV)-naphthalocyanine, Photochem. Photobiol., 59 (1994) 362-365.
4. D. Wöhrle, M. Shopova, S., A. Milev, V. Mantareva and K. Krastev, Liposome-delivered Zn(II)-2,3 naphthalocyanines as potential sensitizers for PDT: synthesis, photochemical, pharmacokinetic and phototherapeutic studies, J. Photochem. Photobiol. B: Biol., 21 (1993) 155-165.
5. P. Firey and M.A.J. Rodgers, Photoproperties of silicon naphthalocyanine: a potential photosensitizer for photodynamic therapy, Photochem. Photobiol., 45 (1987) 535-538.
6. C.V. Schönermark, A. Volkmer, S. Müller. D. Wöhrle and B. Röder, Spectroscopic studies on Si-phthalocyanines and Si-naphthalocyanines, in: D. Brault, G. Jori, J. Moan and B. Ehrenherg (eds.), Photodynamic Therapy of Cancer II, Vol. 2325, SPIE Proc. Bellingham, WA, 1994, pp. 339-348.
7. M. Soncin, L. Polo, E. Reddi, G. Jori, M.E. Kenney, S. Chang and M.A.J. Rodgers, Effect of axial ligation and delivery system on the tumour-localizing and photosensitizing properties of Ge(IV)-octabutoxy-phthalocyanines, Br. J. Cancer, 71 (1995) 727-731.
8. N. Michailov, M. Peeva, I. Angelov, D. Wöhrle, S. Müller, G. Jori, F. Ricchelli and M. Shopova, Fluence rate effects on photodynamic therapy of B16 pigmented melanoma, J. Photochem. Photobiol. B: Biol., 37 (1997) 154-157.
9. S. Müller, V. Mantareva, N. Stoichkova, H. Kliesch, A. Sobbi, D. Wöhrle and M. Shopova, Tetraamido-substituted 2,3-naphthalocyanine-Zn(II)complexes as phototherapeutic agents: synthesis, comparative photochemical and photobiological studies, J. Photochem. Photobiol. B: Biol., 35 (1996) 167-174.
10. J.D. Spikes, Phthalocyanines as photosensitizers in biological systems and for the photodynamic therapy of tumours, Photochem. Photobiol., 43 (1986) 691-699.
11. R. Biolo, G. Jori, M. Soncin, B. Rihter, M.E. Kenney and M.A.J. Rodgers, Effect of photosensitizer delivery system and irradiation parameters on the efficiency of photodynamic therapy of B16 pigmented melanoma in mice, Photochem. Photobiol., 63 (2) (1996) 224-228.
12. M. Leunig, A. Leunig, P. Lankes and A.E. Goetz, Evaluation of photodynamic therapy-induced heating of hamster melanoma and its effect on local tumour eradication, Int. J. Hyperthermia, 10 (1994) 297-306.
13. G. Jori, In vivo transport and pharmacokinetic behaviour of tumours photosensitizers, in: G. Bock and S. Harnett (eds.), Photosensitizing compounds: their chemistry, biology and clinical use, Ciba Foundation Symposium 146, Wiley, Chichester, 1989, pp. 78-94.
14. 2, in: T.J. Dougherty and A. Katzir (eds.), Photodynamic therapy: Mechanisms II, Vol. 1203, SPIE Proc., Bellingham, WA, 1990, pp. 118-125.
15. J.C. Mazière, P. Morlière and R. Santus, The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers for the photodynamic therapy of tumours, J. Photochem. Photobiol. B: Biol., 8 (1991) 351-360.
16. L.O. Svaasand, E. Martinelli, C.J. Gomer and E.A. Profio, Optical characteristics of intraocular tumours in the visible and near-infrared, in: T.J. Dougherty and A. Katzir (eds.), Photodynamic therapy: Mechanisms II. Vol. 1203, SPIE Proc., Bellingham, WA, 1990, pp. 2-21.
17. 1 variant, Cancer Lett., 24 (1984) 57-63.